Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Mode Medical Implant Manufacturer | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to compare one- and two-stage techniques for short implant surgery in diabetes. The main questions it aims to answer are:
Participants will come for their 3rd, 6th and 12th month controls.
Researchers will also test one- and two-stage short implant surgeries in a control group of healthy individuals. Thus, the effects of diabetes on these two techniques will be better understood by comparing them with the healthy control group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diabetic patients | Active Comparator |
| |
| Healthy patient | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| One stage implant surgery | Procedure | It is a technique in which the healing cap is connected to the implant at the stage of implant placement. |
|
| Measure | Description | Time Frame |
|---|---|---|
| One-year survival of the implant | To observe whether the implant is performing its function. The implant continues to support the tooth connected to it. | At the end of 12 months of follow-up from the surgery in which the implant was placed in the bone |
| Evaluation of the status of osseointegration | Fusion of the dental implant with the bone at the microscopic level. Osseointegration will be evaluated as successful or unsuccessful. Successful osseointegration is defined by no mobility in the implant, no radiolucency around the implant on radiography, and no pain in the implant. Otherwise, the osseointegration of the implant is considered unsuccessful. | Three months after the implant is placed in the bone. (At the end of three months) |
| Measure | Description | Time Frame |
|---|---|---|
| Implant Stability Quotient (ISQ Value) | The value obtained by the resonance frequency analysis (RFA) device used to measure the primary stability of dental implants. The RFA technique is based on continual excitation of the implant through dynamic vibration analysis. A transducer is connected to an implant, which is excited over a range of sound frequencies with subsequent measurement of the vibratory oscillation of the implant. It is a non-invasive technique. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Split-mouth study
Not provided
Not provided
Not provided
| Two stage implant surgery | Procedure | It is a technique in which the healing cap is connected to the implant three months after the implant is placed. |
|
| 1- Surgical stage where the implant is placed; 2- Three months after the implant is placed in the bone. At the end of three months |
| Marginal bone level change | It defines the change in the marginal bone level in the neck area of the implant. It is determined by radiographic examination. The initial radiograph is compared with the radiograph at the end of three months. In measurements where the implant platform is the reference point, bone level changes are calculated in mm. | 1- Surgical stage where the implant is placed; 2- Three months after the implant is placed in the bone; 3- Six months after the implant is placed in the bone; 4- Twelve months after the implant is placed in the bone |